Expanding the Spectrum of Early Neuroradiologic Findings in β Propeller Protein-Associated Neurodegeneration

References

1. 1.↵
   1. Wilson JL,
   2. Gregory A,
   3. Kurian MA, et al

   ; BPAN Guideline Contributing Author Group. Consensus clinical management guideline for beta-propeller protein-associated neurodegeneration. Dev Med Child Neurol 2021;63:1402–09 doi:10.1111/dmcn.14980 pmid:34347296

   CrossRefPubMed
2. 2.↵
   1. Saitsu H,
   2. Nishimura T,
   3. Muramatsu K, et al

   . De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet 2013;45:445–49, 449e1 doi:10.1038/ng.2562 pmid:23435086

   CrossRefPubMed
3. 3.↵
   1. Hayflick SJ,
   2. Kruer MC,
   3. Gregory A, et al

   . Beta-propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain 2013;136:1708–17 doi:10.1093/brain/awt095 pmid:23687123

   CrossRefPubMed
4. 4.↵
   1. Paudel R,
   2. Li A,
   3. Wiethoff S, et al

   . Neuropathology of beta-propeller protein associated neurodegeneration (BPAN): a new tauopathy. Acta Neuropathol Commun 2015;3:39 doi:10.1186/s40478-015-0221-3 pmid:26123052

   CrossRefPubMed
5. 5.↵
   1. Kimura Y,
   2. Sato N,
   3. Ishiyama A, et al

   . Serial MRI alterations of pediatric patients with beta-propeller protein associated neurodegeneration (BPAN). J Neuroradiol 2021;48:88–93 doi:10.1016/j.neurad.2020.04.002 pmid:32335071

   CrossRefPubMed
6. 6.↵
   1. Adang LA,
   2. Pizzino A,
   3. Malhotra A, et al

   . Phenotypic and imaging spectrum associated with WDR45. Pediatr Neurol 2020;109:56–62 doi:10.1016/j.pediatrneurol.2020.03.005 pmid:32387008

   CrossRefPubMed
7. 7.↵
   1. Russo C,
   2. Ardissone A,
   3. Freri E, et al

   . Substantia nigra swelling and dentate nucleus T2 hyperintensity may be early magnetic resonance imaging signs of β-propeller protein-associated neurodegeneration. Mov Disord Clin Pract 2019;6:51–56 doi:10.1002/mdc3.12693 pmid:30746416

   CrossRefPubMed
8. 8.↵
   1. Schulz A,
   2. Ajayi T,
   3. Specchio N, et al

   . Study of intraventricular cerliponase alfa for CLN2 disease. N Engl J Med 2018;378:1898–1907 doi:10.1056/NEJMoa1712649 pmid:29688815

   CrossRefPubMed
9. 9.↵
   1. Adam MP,
   2. Ardinger HH,
   3. Pagon RA, et al

   1. Gregory A,
   2. Kurian MA,
   3. Haack T, et al

   . Beta-propeller protein-associated neurodegeneration. In: Adam MP, Ardinger HH, Pagon RA, et al. eds. GeneReviews University of Washington; 2016
10. 10.↵
    1. Willoughby J,
    2. Duff-Farrier C,
    3. Desurkar A, et al

    . Functional mRNA analysis reveals aberrant splicing caused by novel intronic mutation in WDR45 in NBIA patient. Am J Med Genet A 2018;176:1049–54 doi:10.1002/ajmg.a.38656 pmid:29681108

    CrossRefPubMed
11. 11.↵
    1. Halefoglu AM,
    2. Yousem DM

    . Susceptibility weighted imaging: clinical applications and future directions. World J Radiol 2018;10:30–45 doi:10.4329/wjr.v10.i4.30 pmid:29849962

    CrossRefPubMed
12. 12.↵
    1. Garbade SF,
    2. Boy N,
    3. Heringer J, et al

    . Age-related changes and reference values of bicaudate ratio and sagittal brainstem diameters on MRI. Neuropediatrics 2018;49:269–75 doi:10.1055/s-0038-1660475 pmid:29871004

    CrossRefPubMed
13. 13.↵
    1. Bermel RA,
    2. Bakshi R,
    3. Tjoa C, et al

    . Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 2002;59:275–80 doi:10.1001/archneur.59.2.275 pmid:11843699

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Maresky HS,
    2. Ben Ely A,
    3. Bartischovsky T, et al

    . MRI measurements of the normal pediatric optic nerve pathway. J Clin Neurosci 2018;48:209–13 doi:10.1016/j.jocn.2017.11.015 pmid:29198418

    CrossRefPubMed
15. 15.↵
    1. McErlean A,
    2. Abdalla K,
    3. Donoghue V, et al

    . The dentate nucleus in children: normal development and patterns of disease. Pediatr Radiol 2010;40:326–39 doi:10.1007/s00247-009-1504-2 pmid:20107778

    CrossRefPubMed
16. 16.↵
    1. Barkovich AJ,
    2. Raybaud C

    . Pediatric Neuroimaging. 6th ed. Lippincott Williams & Wilkins; 2018
17. 17.↵
    1. Ishiyama A,
    2. Kimura Y,
    3. Iida A, et al

    . Transient swelling in the globus pallidus and substantia nigra in childhood suggests SENDA/BPAN. Neurology 2018;90:974–76 doi:10.1212/WNL.0000000000005564 pmid:29695595

    Abstract/FREE Full Text
18. 18.↵
    1. Maroofian R,
    2. Gubas A,
    3. Kaiyrzhanov R, et al

    . Homozygous missense WIPI2 variants cause a congenital disorder of autophagy with neurodevelopmental impairments of variable clinical severity and disease course. Brain Commun 2021;3:fcab183 doi:10.1093/braincomms/fcab183 pmid:34557665

    CrossRefPubMed
19. 19.↵
    1. Proikas-Cezanne T,
    2. Takacs Z,
    3. Donnes P, et al

    . WIPI proteins: essential PtdIns3P effectors at the nascent autophagosome. J Cell Sci 2015;128:207–17 doi:10.1242/jcs.146258 pmid:25568150

    Abstract/FREE Full Text
20. 20.↵
    1. Adam MP,
    2. Everman DB,
    3. Mirzaa GM

    1. Gregory A,
    2. Hayflick S

    . Neurodegeneration with brain iron accumulation disorders: overview. In: Adam MP, Everman DB, Mirzaa GM, eds. GeneReviews University of Washington, 1993
21. 21.↵
    1. Saneto RP,
    2. Friedman SD,
    3. Shaw DW

    . Neuroimaging of mitochondrial disease. Mitochondrion 2008;8:396–413 doi:10.1016/j.mito.2008.05.003 pmid:18590986

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Hayflick SJ,
    2. Kurian MA,
    3. Hogarth P

    . Neurodegeneration with brain iron accumulation. Handb Clin Neurol 2018;147:293–305 doi:10.1016/B978-0-444-63233-3.00019-1 pmid:29325618

    CrossRefPubMed
23. 23.↵
    1. Rathore GS,
    2. Schaaf CP,
    3. Stocco AJ

    . Novel mutation of the WDR45 gene causing beta-propeller protein-associated neurodegeneration. Mov Disord 2014;29:574–75 doi:10.1002/mds.25868 pmid:24610255

    CrossRefPubMed